Colorado

NACDS submitted a statement to the Senate Business, Labor and Technology Committee in support of SB19-079, legislation that would require Schedule II, III and IV controlled substance prescriptions to be electronically prescribed. The legislation subsequently passed the Senate and was introduced in the House and assigned to the Public Health Care & Human Services Committee.

Also in Colorado…NACDS submitted a statement to the Senate Health and Human Services Committee opposing SB19-005, legislation establishing a commercial prescription drug importation program in the state. NACDS outlined how the legislation would violate federal law against drug importation, undermine federally mandated security protections of the drug supply chain and increase the risk of counterfeit drugs in the state’s drug supply chain and thereby compromise patient safety.

For more information, contact NACDS’ Mary Staples at 817-442-1155.